Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. - Wikidata - awgldk - TriplyDB

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

http://www.wikidata.org/entity/Q37023006

about

Bisphosphonates for osteoporosis in people with cystic fibrosis Bisphosphonates for osteoporosis in people with cystic fibrosis Bisphosphonates for osteoporosis in people with cystic fibrosis Hypercalcemia of Malignancy: An Update on Pathogenesis and Management Novel molecular pathways in Gorham disease: implications for treatment Exposure to bisphosphonates and risk of colorectal cancer Dental complications and management of patients on bisphosphonate therapy: A review article Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.Dynamic visualization of RANKL and Th17-mediated osteoclast function.Treatment of multiple myeloma bone disease: experimental and clinical data.Recent advances in bone-targeted therapies of metastatic prostate cancer Tetra- to dodecanuclear oxomolybdate complexes with functionalized bisphosphonate ligands: activity in killing tumor cells Histology of 8 atypical femoral fractures: remodeling but no healing Statins Are Associated With Reduced Mortality in Multiple Myeloma.Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3 Bone health and prostate cancer.Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment Ewing sarcoma cells express RANKL and support osteoclastogenesis.Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studies Update on denosumab in postmenopausal osteoporosis--recent clinical data.Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis Bisphosphonate remains highly localized after elution from porous implants Bisphosphonates for steroid-induced osteoporosis.Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.Bisphosphonates pathway.Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.Osteoclast activity modulates B-cell development in the bone marrow Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma.The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms.Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.Effect of risedronate on bone in renal transplant recipients.

P2860

Q24197936-9CEE1F1B-7AD3-4552-A49E-A6DDA59C36C8 Q24200401-B011C24D-A3C7-4A77-9C70-90AC3FFF96C3 Q24239980-C7467A91-DBB1-471C-B094-9AE7F58546FF Q26771719-5E7617C7-A91B-4E49-AE77-8CCD92BB2316 Q27005629-9E7F6062-7841-4DF5-B845-070B1396994B Q27022446-E9150029-638A-43C2-89FA-FD7F16B8C2EB Q27022492-51FE19E5-C64C-4E73-961F-D087156BF3DD Q27654261-6A097550-955F-45DB-A262-EA18265D5645 Q28288666-92B8E5C8-F6AF-473D-B14B-487715B961E7 Q30533914-96F1A97A-CDCA-4AA4-B731-01874712EEB7 Q30868833-2E246783-2D57-465E-889C-AE7781845979 Q33703763-6CE119C3-AD59-4BCB-A91C-2D1F445D036C Q33722273-C6C830FF-4AF1-490B-A633-791BBE448726 Q33774987-F22081BC-7FB2-45B1-A6D3-17292A07E323 Q33816591-00AE3C9F-4626-4796-A81D-BA623C3E8032 Q33911367-38902825-6805-4059-A5CA-CC177B72889E Q33977536-47A1EC11-50C6-4B88-8F09-2B155A7D1BF7 Q34009569-00E9B238-7663-4CAB-9849-2AC2E25825C0 Q34023772-D1C38742-B9C7-4299-974F-1771B72E07FE Q34153137-C82E08B1-6BEE-475E-A6A4-2C423B4CBEBE Q34182079-226AA41B-BC31-4BBD-93CC-6CEC7F3CE5CE Q34183161-271B1CC1-C21B-4A20-B049-32739E784A43 Q34238507-CA3DCC6B-7C7D-4F2B-B203-E90A9CE81044 Q34300462-BC183FDA-C328-4D39-99FE-187ED3CF4439 Q34360661-7A2E73E6-4187-4B25-B538-6F9EFECB9A17 Q34469883-0D873554-90E2-4F9E-9B5E-96FFF0011EEE Q34477058-96922382-8ABF-415A-864F-D2728F7A9C01 Q34542004-5479AFD8-2E2E-431B-8DA3-D2223D07C926 Q34645740-8D36745E-61EB-42E2-BAE0-B8E7BDD77634 Q34905878-7FE60660-51A3-42CB-B4B4-13DFC9F16058 Q34967135-3E376731-2CC3-45DE-8503-B2B6EFAC7919 Q35092602-FBF9E12A-4B15-488A-AA17-7C65B070B0AB Q35155516-6F578BE5-FFBB-4609-A8AD-52376DD75863 Q35348955-70B0A765-0968-4E1D-98AB-0B480E07632D Q35441390-413A99A6-3EBC-402D-B97E-40014AC11440 Q35584866-AE18B105-0A77-487A-BA6F-265B60678E5A Q35723178-8A346C78-5BF0-4D2D-A91C-383F66ABD2C9 Q35780856-A92F84DC-FB95-4E52-9637-36E052B63F7D Q35867314-0CA95220-3A3D-4488-8EF4-A2EDA7D46508 Q36109164-F60465A7-2B91-4AAE-8349-18796C29B68B

P2860

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

http://www.wikidata.org/entity/Q37023006

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@en

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@nl

type

label

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@en

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@nl

prefLabel

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@en

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@nl

P1433

Q37023006-71C9D439-4BD5-4C06-BE89-10BC28457F1E

P1476

Q37023006-FB750F12-4DDC-4769-9C87-D7721DE8E8D8

P2093

Q37023006-060364EB-BB51-43F5-B071-548E89D9C8FC

Q37023006-07426D68-3511-4036-879B-FEBE0997E4C8

Q37023006-0D85F6C7-09FE-42FF-B898-DD93FF0A9E65

Q37023006-1914F10A-9C90-44F5-B462-BD2A37F9EE02

Q37023006-1D028F40-477D-494B-874A-55408E987A68

Q37023006-20316A09-CF98-4B86-856E-E9381C1DA2EB

Q37023006-35604619-7E99-4C8A-8005-501FEF37FDB8

Q37023006-7A3E0505-AD3A-4563-831C-C58856B38C79

Q37023006-83BA52E7-F334-49AA-AF7A-8D905073B5C4

Q37023006-8A730272-9002-4DD3-B83B-A2872A463240

P304

Q37023006-5697BE28-360B-4D30-B51C-B85AA0C9A7A7

P31

Q37023006-0D0AA283-4825-43BD-8778-0D1ADC99982C

P356

Q37023006-B17C8FEF-1E25-4ACC-AF04-1153F3508742

P407

Q37023006-C800698C-05F6-440B-9490-493058CCBF36

P478

Q37023006-2CDD811A-A3AD-4123-B6CF-6739AD611632

P577

Q37023006-28F1CBBF-1EA4-4A1F-8714-D7EACE290B2D

P698

Q37023006-48FC876B-C2AA-4CA7-A185-B5EF2D7C661C

P356

ANNALS.1402.089

P1433

Annals of the New York Academy of Sciences

P1476

Bisphosphonates: an update on ...... e relate to clinical efficacy.

@en

P2093

Aaron Kwaasi

http://www.w3.org/2001/XMLSchema#string

Bobby L Barnett

http://www.w3.org/2001/XMLSchema#string

Frank H Ebetino

http://www.w3.org/2001/XMLSchema#string

Fraser P Coxon

http://www.w3.org/2001/XMLSchema#string

James E Dunford

http://www.w3.org/2001/XMLSchema#string

James T Triffitt

http://www.w3.org/2001/XMLSchema#string

Kathryn L Kavanagh

http://www.w3.org/2001/XMLSchema#string

Mark W Lundy

http://www.w3.org/2001/XMLSchema#string

Michael J Rogers

http://www.w3.org/2001/XMLSchema#string

Nelson B Watts

http://www.w3.org/2001/XMLSchema#string

P304

209-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1402.089

http://www.w3.org/2001/XMLSchema#string

P407

P478

1117

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18056045

http://www.w3.org/2001/XMLSchema#string